# Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

> **NCT00581607** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 43 (actual)

## Conditions studied

- Sarcoidosis
- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Bosentan
- **DRUG:** Placebo
- **DRUG:** Bosentan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00581607
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2013-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00581607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00581607, "Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00581607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*